The medicine cabinet: What's in it, why, and can we change the contents?

Thomas W. Croghan, Patricia M. Pittman

    Research output: Contribution to journalReview article

    Abstract

    The failure of the pharmaceutical industry to produce drugs for common chronic diseases, emerging diseases, and the potential threats of bioterrorism or the spread of tropical diseases contrasts sharply with the industry's output of lifestyle and "me-too" drugs. In this paper we review the decision-making process that resulted in our current portfolio of medicines and offer several alternatives to better align business incentives with medical need.

    Original languageEnglish (US)
    Pages (from-to)23-33
    Number of pages11
    JournalHealth Affairs
    Volume23
    Issue number1
    DOIs
    StatePublished - Jan 1 2004

      Fingerprint

    ASJC Scopus subject areas

    • Health Policy

    Cite this